Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Cancer Discovery|August 9, 2014
Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinomaAlexander Stoeck, Serguei Lejnine, Andrew Truong, et al.
Blood Cancer Discovery|November 14, 2025
Composition and functional state of T and NK cells in the extramedullary myeloma tumor microenvironmentAnjana Anilkumar Sithara, Veronika Kapustova, David Zihala, et al.
Nature Genetics|March 4, 2014
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemiaBirgit Knoechel, Justine E Roderick, Kaylyn E Williamson, et al.
Blood Advances|May 8, 2020
Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AMLSung Choe, Hongfang Wang, Courtney D DiNardo, et al.
Plos One|February 18, 2010
Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptorsMiguel Aste-Amézaga, Ningyan Zhang, Janet E Lineberger, et al.
Plos One|July 5, 2013
Gauging NOTCH1 Activation in Cancer Using ImmunohistochemistryMichael J Kluk, Todd Ashworth, Hongfang Wang, et al.
Blood|October 7, 2020
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 studyEytan M Stein, Courtney D DiNardo, Amir T Fathi, et al.
Blood|December 17, 2019
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemiaGail J Roboz, Courtney D DiNardo, Eytan M Stein, et al.
The New England Journal of Medicine|June 5, 2018
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AMLCourtney D DiNardo, Eytan M Stein, Stéphane de Botton, et al.
Pageof 17